| Name | Title | Contact Details |
|---|
Texas Physical Therapy Specialists P.C is a New Braunfels, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ENPRO is a Addison, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
IRIDEX Corporation is a worldwide leader in developing, manufacturing, marketing and selling innovative and cost-effective medical laser systems. The company has the largest global installed base of solid-state lasers and focuses on developing laser products that are clinically effective, reliable, portable, versatile, and affordable.
We are one of the world`s leading suppliers of processing solutions to the ophthalmic and precision-optical industry. SCHNEIDER innovations set the pace – in freeform generating and polishing of eye glasses, in grinding and polishing of precision aspheres, and in process metrology. We set technical standards and open up new and more productive solutions to our customers. We are distinctive for our development of new technologies and swift translation of technological concepts into customer-oriented innovations.
NeuroOne Medical Technologies Incorporated (Ticker: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy. Today, our attention is on the development and commercialization of patented thin-film, cortical electrode technology for intracranial electroencephalography (iEEG) and depth electrodes for stereoelectroencephalography (sEEG) recording of brain activity. The products currently available in these categories have significant limitations such as low recording resolution and high risk of infection. NeuroOne believes our technology can address these unmet needs upon initial commercialization with pipeline technology to advance the field by enabling minimally invasive techniques and all-in-one diagnostic and therapeutic options. While our initial focus is Epilepsy, future applications in Parkinson`s disease, Essential tremors, and Dystonia are within sight. NeuroOne technologies will be presented to a well-defined market, eager for the advancement they bring. There are 188 hospital centers licensed to perform epilepsy surgical procedures in the U.S. The current addressable market opportunity for is approximately $525.6 million. As more patients choose the minimally invasive procedures made available by NeuroOne technology, the future opportunity is estimated to be approximately $14.9 billion with full market penetration.